Licensing Western products to sell in Asia
Total Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
1,121
NCT01435863
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2011
Completion: Jul 31, 2015
NCT01689220
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea
Start: Sep 30, 2012
Completion: Sep 30, 2014
NCT01937156
A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting
Phase: Phase 3
Start: Aug 31, 2013
Completion: Feb 28, 2014
NCT02653976
A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Phase: Phase 2
Start: Mar 25, 2016
Completion: Jun 17, 2021
NCT03546985
A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis
Phase: N/A
Start: Dec 26, 2017
Completion: May 25, 2018
NCT03654729
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Role: Collaborator
Start: Nov 7, 2018
Completion: Aug 31, 2020
NCT04034355
Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer
Start: Jan 7, 2019
NCT05075876
Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites
Start: Oct 13, 2021
Completion: Dec 3, 2021
Loading map...